Related Experiment Videos
Heterocyclic compounds as inflammation inhibitors
Sham M Sondhi1, Nidhi Singhal, Monika Johar
1Department of Chemistry, University of Roorkee, Roorkee, 247667, INDIA.
Current Medicinal Chemistry
|May 8, 2003
Summary
Non-steroidal anti-inflammatory drugs (NSAIDs) cause toxicity. This study summarizes novel heterocyclic compounds synthesized as safer, more effective anti-inflammatory agents, offering potential therapeutic benefits.
Area of Science:
- Medicinal Chemistry
- Pharmacology
Background:
- Clinical use of non-steroidal anti-inflammatory drugs (NSAIDs) is linked to significant gastrointestinal and kidney toxicity.
- Existing strategies to mitigate NSAID toxicity include formulation, co-administration, and chemical modification.
Purpose of the Study:
- To summarize recent findings on the synthesis of novel heterocyclic compounds as potential anti-inflammatory agents.
- To explore the role of these synthesized compounds in inhibiting inflammation.
Main Methods:
- Literature review of various approaches to overcome NSAID toxicity.
- Focus on the synthesis of heterocyclic compounds, including pyrimidines, imidazole, benzimidazole, thiazole, thiazolidine, acridine, and thiourea derivatives.
- Evaluation of synthesized compounds for their anti-inflammatory properties.
Main Results:
- Several classes of heterocyclic compounds have been synthesized and investigated for anti-inflammatory activity.
- Specific examples include pyrimidines, imidazoles, benzimidazoles, thiazoles, thiazolidines, acridines, and thioureas.
- These compounds show promise as inflammation inhibitors.
Conclusions:
- Novel heterocyclic compounds represent a promising avenue for developing safer and more effective anti-inflammatory drugs.
- The synthesized compounds demonstrate potential for reducing inflammation with potentially fewer side effects than traditional NSAIDs.